Published in Epilepsia on February 01, 2005
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology (2008) 1.89
Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy. Mayo Clin Proc (2009) 1.29
Anti-epileptic medication and bone health. Osteoporos Int (2006) 1.20
Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis (2006) 1.14
Antiepileptics and bone health. Ther Adv Musculoskelet Dis (2011) 1.06
Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology (2008) 1.03
Injuries in epilepsy: a review of its prevalence, risk factors, type of injuries and prevention. Neurol Int (2009) 0.92
Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it? J Pediatr Neurosci (2013) 0.83
Effects of Treatment on Endocrine Function in Patients with Epilepsy. Curr Treat Options Neurol (2005) 0.82
The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci (2016) 0.81
Dietary Intakes and Nutritional Issues in Neurologically Impaired Children. Nutrients (2015) 0.81
Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs. Epilepsy Behav (2011) 0.80
Osteoporosis-related simultaneous four joints fractures and dislocation after a seizure: a case report. J Osteoporos (2010) 0.80
Bone status in patients with epilepsy: relationship to markers of bone remodeling. Front Neurol (2014) 0.80
Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis. J Zhejiang Univ Sci B (2015) 0.80
A case of central cord syndrome related status epilepticus - a case report -. Ann Rehabil Med (2011) 0.77
Injuries in adolescents with childhood-onset epilepsy compared with sibling controls. J Pediatr (2013) 0.75
Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy. Clin Psychopharmacol Neurosci (2016) 0.75
Uncommon t12 burst fracture after an epileptic crisis. Case Rep Orthop (2011) 0.75
Women and epilepsy. J Pediatr Pharmacol Ther (2009) 0.75
Injuries in Patients with Epilepsy and Some Factors Associated with Injury. Noro Psikiyatr Ars (2013) 0.75
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels. Eur J Clin Pharmacol (2007) 0.75
A prescription for better prescribing. BMJ (2006) 5.31
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr (2007) 4.34
Clinical pharmacology--too young to die? Lancet (2006) 4.32
Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology (2011) 4.06
Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol (2008) 3.52
Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol (2003) 3.37
The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol (2004) 3.35
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension (2009) 2.38
A spoonful of sugar? Tomorrow's doctors 2002. Br J Clin Pharmacol (2002) 2.32
Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension (2006) 2.30
Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology (2013) 2.24
Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol (2006) 2.19
Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol (2002) 2.14
Nitric oxide regulates local arterial distensibility in vivo. Circulation (2002) 2.04
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis (2011) 1.80
Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes (2006) 1.79
COX-2 selective inhibitors--important lessons learned. Lancet (2005) 1.74
Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med (2012) 1.70
Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens (2002) 1.66
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury. J Immunol (2011) 1.63
Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol (2012) 1.61
Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf (2012) 1.61
Learning curves, taking instructions, and patient safety: using a theoretical domains framework in an interview study to investigate prescribing errors among trainee doctors. Implement Sci (2012) 1.60
Impact on hypertension control of a patient-held guideline: a randomised controlled trial. Br J Gen Pract (2006) 1.56
Poor prescribing is continual. BMJ (2006) 1.55
Non-invasive measurement of cardiac output in patients with chronic heart failure. Blood Press Monit (2004) 1.51
Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem (2008) 1.48
Medical students' perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers? Clin Infect Dis (2013) 1.47
Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J Am Coll Cardiol (2008) 1.47
Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury. Cardiovasc Res (2012) 1.46
New guidelines for drive-by renal arteriography may lead to an unjustifiable increase in percutaneous intervention. Heart (2007) 1.46
Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension (2009) 1.46
Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension. Hypertension (2010) 1.45
Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol (2006) 1.43
Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol (2002) 1.42
The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol (2006) 1.42
Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis. Am J Gastroenterol (2004) 1.41
Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol (2002) 1.40
Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial. Crit Care Med (2007) 1.40
Nitric oxide and the regulation of arterial elasticity: right idea, wrong vascular bed? Hypertension (2002) 1.38
Vascular effects of apelin in vivo in man. J Am Coll Cardiol (2008) 1.33
Strain and temperature sensitivity of a single-mode polymer optical fiber. Opt Lett (2005) 1.33
Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol (2011) 1.32
Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug. Exp Biol Med (Maywood) (2006) 1.31
Quantification of human urinary exosomes by nanoparticle tracking analysis. J Physiol (2013) 1.31
Arterial stiffness and hypertension: emerging concepts. Hypertension (2009) 1.30
Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis (2013) 1.28
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation (2004) 1.27
Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension (2006) 1.26
Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol (2005) 1.24
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology (2002) 1.18
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. Hypertension (2011) 1.15
Educating European (junior) doctors for safe prescribing. Basic Clin Pharmacol Toxicol (2007) 1.15
Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension (2008) 1.13
Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products. Br J Clin Pharmacol (2006) 1.13
The road from AKI to CKD: the role of endothelin. Kidney Int (2013) 1.09
Impact of a focussed teaching programme on practical prescribing skills among final year medical students. Br J Clin Pharmacol (2011) 1.09
Cardiovascular effects of acute oxygen administration in healthy adults. J Cardiovasc Pharmacol (2003) 1.08
Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting. Diabetes Care (2005) 1.07
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis. Am J Physiol Renal Physiol (2009) 1.06
Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease. J Alzheimers Dis (2008) 1.05
Junior doctors' perceptions of their self-efficacy in prescribing, their prescribing errors and the possible causes of errors. Br J Clin Pharmacol (2013) 1.05
Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension (2002) 1.03
Prognosis without treatment as a modifier in health economic assessments. BMJ (2005) 1.02
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab (2007) 1.02
Continuous wave ultraviolet light-induced fiber Bragg gratings in few- and single-mode microstructured polymer optical fibers. Opt Lett (2005) 1.02
Nebivolol increases arterial distensibility in vivo. Hypertension (2004) 0.99
Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) (2006) 0.99
Humidity insensitive TOPAS polymer fiber Bragg grating sensor. Opt Express (2011) 0.97
Letter by Payne and Webb regarding article, "agreement among cardiovascular disease risk calculators". Circulation (2013) 0.97
Endothelium-derived endothelin-1. Pflugers Arch (2009) 0.97
Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies. Clin Drug Investig (2008) 0.97
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc Res (2002) 0.95
Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomography. PLoS One (2011) 0.95
Selective and mixed endothelin receptor antagonism in cardiovascular disease. Trends Pharmacol Sci (2007) 0.93
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. J Child Adolesc Psychopharmacol (2010) 0.93
Nitric oxide donor drugs: current status and future trends. Expert Opin Investig Drugs (2002) 0.93
The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes. Br J Clin Pharmacol (2008) 0.92
Potential therapeutic role of phosphodiesterase type 5 inhibition in hypertension and chronic kidney disease. Hypertension (2013) 0.92
Systemic and regional changes in plasma endothelin following transient increase in portal pressure. Liver Transpl (2003) 0.91
Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr (2006) 0.91
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD. J Am Soc Nephrol (2012) 0.91
Oxygen therapy in acute medical care. BMJ (2002) 0.91
Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens (2004) 0.90
No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans. Br J Clin Pharmacol (2002) 0.90
Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. J Appl Physiol (1985) (2006) 0.90
Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism. J Am Soc Nephrol (2004) 0.90
25-Hydroxycholesterol, 7beta-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res (2007) 0.90
Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression. Atherosclerosis (2006) 0.90
The UK's NHS and pharma: need for more clinical pharmacologists. Lancet (2009) 0.90
Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP). BMC Pharmacol Toxicol (2013) 0.90
Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr (2006) 0.89
Generation of infrared surface plasmon resonances with high refractive index sensitivity utilizing tilted fiber Bragg gratings. Appl Opt (2007) 0.89
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. Nephrol Dial Transplant (2007) 0.89
Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Med (2004) 0.88